Full Press Release Details
BASKING RIDGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report first quarter ended March 31, 2019 financial results after the close of the market on Tuesday May 14, 2019. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.
| Tuesday, May 14 @ 4:30pm Eastern Time | |||||||
| Domestic: | 877-407-4018 | ||||||
| International: | 201-689-8471 | ||||||
| Conference ID: | 13690296 | ||||||
| Webcast: | http://public.viavid.com/index.php?id=134335 |
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
LifeSci Public Relations